Commonwealth Medicine, Clinical Pharmacy Services
Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacoeconomics and Pharmaceutical Economics | Pharmacy Administration, Policy and Regulation
This presentation provides an overview of the hepatitis C virus monitoring program implemented for state Medicaid to contain costs and to promote optimal member care. Key clinical and economic outcomes of the monitoring program are highlighted and formulary management strategies for novel hepatitis C virus agents identified.
Presented at the American Drug Utilization Review Society 2015 Conference.
Hepatitis C medication management, Medicaid, pharmacy, clinical management, drug utilization review, prescriber outreach and education, prior authorization, Massachusetts
DOI of Published Version
American Drug Utilization Review Society 2015
Lavitas P. (2015). One State's Perspective on the Management of Hepatitis C Drugs. Commonwealth Medicine Publications. https://doi.org/10.13028/nfpq-b240. Retrieved from https://escholarship.umassmed.edu/commed_pubs/119
Health Economics Commons, Health Law and Policy Commons, Health Policy Commons, Health Services Administration Commons, Health Services Research Commons, Pharmacoeconomics and Pharmaceutical Economics Commons, Pharmacy Administration, Policy and Regulation Commons